Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo.

PubWeight™: 1.51‹?› | Rank: Top 4%

🔗 View Article (PMID 12692590)

Published in Gene Ther on April 01, 2003

Authors

A Al-Khaldi1, N Eliopoulos, D Martineau, L Lejeune, K Lachapelle, J Galipeau

Author Affiliations

1: McGill University Health Center, Montreal, Quebec, Canada.

Articles citing this

Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells (2011) 2.74

Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood (2008) 1.63

Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev (2009) 1.41

Cell based therapies for ischemic stroke: from basic science to bedside. Prog Neurobiol (2013) 1.39

Mesenchymal stem cells and cardiac repair. J Cell Mol Med (2008) 1.37

Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. J Cell Mol Med (2007) 1.33

Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats. Diabetes (2008) 1.29

Comparing the osteogenic potential of canine mesenchymal stem cells derived from adipose tissues, bone marrow, umbilical cord blood, and Wharton's jelly for treating bone defects. J Vet Sci (2012) 1.19

Function of mesenchymal stem cells following loading of gold nanotracers. Int J Nanomedicine (2011) 1.14

Therapeutic implications of mesenchymal stem cells in liver injury. J Biomed Biotechnol (2011) 1.02

A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. Can J Cardiol (2007) 1.01

High-throughput functional microRNAs profiling by recombinant AAV-based microRNA sensor arrays. PLoS One (2012) 1.01

Atmospheric oxygen inhibits growth and differentiation of marrow-derived mouse mesenchymal stem cells via a p53-dependent mechanism: implications for long-term culture expansion. Stem Cells (2012) 1.00

Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy. J Cell Mol Med (2008) 0.99

Mesenchymal stromal cells for cardiovascular disease. J Cardiovasc Dis Res (2011) 0.98

Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke. Neurobiol Dis (2009) 0.98

The bone marrow microenvironment as a sanctuary for minimal residual disease in CML. Biochem Pharmacol (2010) 0.96

The dual effect of mesenchymal stem cells on tumour growth and tumour angiogenesis. Stem Cell Res Ther (2013) 0.95

Detection of osteogenic differentiation by differential mineralized matrix production in mesenchymal stromal cells by Raman spectroscopy. PLoS One (2013) 0.91

Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells. Front Cell Dev Biol (2014) 0.91

Hemato-vascular origins of endothelial progenitor cells? Microvasc Res (2010) 0.91

A comparison of the reparative and angiogenic properties of mesenchymal stem cells derived from the bone marrow of BALB/c and C57/BL6 mice in a model of limb ischemia. Stem Cell Res Ther (2013) 0.89

Aortic implantation of mesenchymal stem cells after aneurysm injury in a porcine model. J Surg Res (2011) 0.89

The bad and the good of mesenchymal stem cells in cancer: Boosters of tumor growth and vehicles for targeted delivery of anticancer agents. World J Stem Cells (2010) 0.88

Electrofusion of mesenchymal stem cells and islet cells for diabetes therapy: a rat model. PLoS One (2013) 0.87

β-Cell regeneration mediated by human bone marrow mesenchymal stem cells. PLoS One (2012) 0.87

Drosha regulates hMSCs cell cycle progression through a miRNA independent mechanism. Int J Biochem Cell Biol (2011) 0.86

The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells. Cancer Gene Ther (2014) 0.86

Density of human bone marrow stromal cells regulates commitment to vascular lineages. Stem Cell Res (2011) 0.85

Mesenchymal stem cells as feeder cells for pancreatic islet transplants. Rev Diabet Stud (2010) 0.84

Mesenchymal stem cells as cellular vectors for pediatric neurological disorders. Brain Res (2014) 0.83

Human mesenchymal stem cells suppress the stretch-induced inflammatory miR-155 and cytokines in bronchial epithelial cells. PLoS One (2013) 0.83

Rapid and dynamic alterations of gene expression profiles of adult porcine bone marrow-derived stem cell in response to hypoxia. Stem Cell Res (2010) 0.83

Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma. Carcinogenesis (2013) 0.83

Mesenchymal stromal cells as supportive cells for hepatocytes. Mol Ther (2009) 0.81

Diabetic Mesenchymal Stem Cells Are Ineffective for Improving Limb Ischemia Due to Their Impaired Angiogenic Capability. Cell Transplant (2014) 0.80

Close interactions between mesenchymal stem cells and neuroblastoma cell lines lead to tumor growth inhibition. PLoS One (2012) 0.79

Dopamine regulates mobilization of mesenchymal stem cells during wound angiogenesis. PLoS One (2012) 0.79

Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma. Int J Radiat Oncol Biol Phys (2014) 0.78

Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets. Nat Rev Drug Discov (2016) 0.77

Stem cells rejuvenate radiation-impaired vasculogenesis in murine distraction osteogenesis. Plast Reconstr Surg (2015) 0.77

Synergistic effect of fibronectin and hepatocyte growth factor on stable cell-matrix adhesion, re-endothelialization, and reconstitution in developing tissue-engineered heart valves. Heart Vessels (2007) 0.77

A mathematical model predicting the coculture dynamics of endothelial and mesenchymal stem cells for tissue regeneration. Tissue Eng Part A (2013) 0.77

Rapidly self-renewing human multipotent marrow stromal cells (hMSC) express sialyl Lewis X and actively adhere to arterial endothelium in a chick embryo model system. PLoS One (2014) 0.76

Cell transplantation into ischemic myocardium using mesenchymal stem cells transfected by vascular endothelial growth factor. Int J Clin Exp Pathol (2014) 0.75

Adipose Stem Cells Display Higher Regenerative Capacities and More Adaptable Electro-Kinetic Properties Compared to Bone Marrow-Derived Mesenchymal Stromal Cells. Sci Rep (2016) 0.75

Effect of bone mesenchymal stem cells transplantation on the micro-environment of early osteonecrosis of the femoral head. Int J Clin Exp Pathol (2015) 0.75

Comparative Therapeutic Effects of Minocycline Treatment and Bone Marrow Mononuclear Cell Transplantation following Striatal Stroke. Oxid Med Cell Longev (2017) 0.75

In-vivo evaluation of subcutaneously implanted cell-loaded apatite microcarriers for osteogenic potency. J Mater Sci Mater Med (2017) 0.75

Articles by these authors

Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry (2010) 1.69

Nucleotide sequence and protein analysis of a complex piscine retrovirus, walleye dermal sarcoma virus. J Virol (1995) 1.47

Perioperative mortality after pneumonectomy: analysis of risk factors and review of the literature. Can J Surg (1997) 1.41

In vivo selection of retrovirally transduced hematopoietic stem cells. Nat Med (1998) 1.33

Mouse P-selectin glycoprotein ligand-1: molecular cloning, chromosomal localization, and expression of a functional P-selectin receptor. Blood (1996) 1.23

Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood (1998) 1.19

Leptospirosis in raccoons in Quebec: 2 case reports and seroprevalence in a recreational area. Can Vet J (1997) 1.14

Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation. Curr Mol Med (2013) 1.12

Realistic analytical phantoms for parallel magnetic resonance imaging. IEEE Trans Med Imaging (2011) 1.12

Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg (2000) 1.12

Possible mechanisms of action of environmental contaminants on St. Lawrence beluga whales (Delphinapterus leucas). Environ Health Perspect (1995) 1.05

Immune plasticity of bone marrow-derived mesenchymal stromal cells. Handb Exp Pharmacol (2007) 1.02

Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma. Cancer Invest (2001) 0.98

Walleye dermal sarcoma virus: OrfA N-terminal end inhibits the activity of a reporter gene directed by eukaryotic promoters and has a negative effect on the growth of fish and mammalian cells. J Virol (1999) 0.98

Fertile homozygous transgenic mice expressing a functional truncated herpes simplex thymidine kinase delta TK gene. Transgenic Res (1998) 0.97

Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis. Mutat Res (2000) 0.96

Transcriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue. J Biol Chem (2001) 0.96

Toxoplasmosis in beluga whales (Delphinapterus leucas) from the St Lawrence estuary: two case reports and a serological survey. J Comp Pathol (2000) 0.96

Basic fibroblast growth factor in Dupuytren's contracture. Am J Pathol (1992) 0.94

Effects of retroviral-mediated MDR1 expression on hematopoietic stem cell self-renewal and differentiation in culture. Ann N Y Acad Sci (1999) 0.94

Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies. Oncogene (2008) 0.93

GMCSF-interleukin fusion cytokines induce novel immune effectors that can serve as biopharmaceuticals for treatment of autoimmunity and cancer. J Intern Med (2011) 0.92

Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications. Hum Gene Ther (2001) 0.92

A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice. Gene Ther (2003) 0.91

Neuronal differentiation and growth control of neuro-2a cells after retroviral gene delivery of connexin43. J Biol Chem (2000) 0.91

The Baller-Gerold syndrome. J Med Genet (1992) 0.90

The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor. J Cell Physiol (1991) 0.90

The expression of saporin, a ribosome-inactivating protein from the plant Saponaria officinalis, in Escherichia coli. J Biol Chem (1993) 0.88

Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia. Leukemia (1997) 0.87

B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cells. Blood (1989) 0.87

Parathyroid hormone-related protein promotes quiescence and survival of serum-deprived chondrocytes by inhibiting rRNA synthesis. J Biol Chem (2001) 0.87

Immunological defects after suicide gene therapy of experimental graft-versus-host disease. Hum Gene Ther (1999) 0.86

Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy. Clin Cancer Res (1999) 0.86

Anti-vector immunoglobulin induced by retroviral vectors. Hum Gene Ther (1997) 0.85

Glucocorticoid-inducible retrovector for regulated transgene expression in genetically engineered bone marrow stromal cells. Hum Gene Ther (2000) 0.85

Inhibition of carcinoma cell growth and metastasis by a vesicular stomatitis virus G-pseudotyped retrovector expressing type I insulin-like growth factor receptor antisense. Hum Gene Ther (2001) 0.85

Phylogenetic and epidemiologic analysis of the walleye dermal sarcoma virus. Virology (1996) 0.85

Effects of in vitro exposure of beluga whale leukocytes to selected organochlorines. J Toxicol Environ Health A (1998) 0.83

Biological and chemical characterization of basic FGF-saporin mitotoxin. Biochem Biophys Res Commun (1989) 0.83

The effects of hemodilution with polyethylene glycol bovine hemoglobin (PEG-Hb) in a conscious porcine model. J Investig Med (1996) 0.83

Transitional Cell Carcinoma of the Urinary Bladder in a Beluga Whale (Delphinapterus leucas). Can Vet J (1985) 0.83

Monocyte derivatives promote angiogenesis and myocyte survival in a model of myocardial infarction. Cell Transplant (2009) 0.82

Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma. Cancer Gene Ther (1999) 0.82

Evaluation of antihuman T lymphocyte saporin immunotoxins potentially useful in human transplantation. Transplantation (1988) 0.82

Evaluation of an inhibitor of DNA methylation, 5-aza-2'-deoxycytidine, for the treatment of lung cancer and the future role of gene therapy. Adv Exp Med Biol (2000) 0.82

Use of polymerase chain reaction and immunohistochemistry for detection of canine adenovirus type 1 in formalin-fixed, paraffin-embedded liver of dogs with chronic hepatitis or cirrhosis. J Vet Diagn Invest (1998) 0.82

Physiological effect of polyethylene glycol conjugation on stroma-free bovine hemoglobin in the conscious dog after partial exchange transfusion. Artif Organs (1997) 0.81

Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene. Cancer Gene Ther (2001) 0.81

PEG-Hemoglobin as a resuscitation solution in the treatment of hypovolemic shock in the anesthetized rat. Artif Organs (1999) 0.81

The Canadian Cooperative Wildlife Health Centre and surveillance of wild animal diseases in Canada. Can Vet J (1997) 0.81

Severe hepatitis resulting from toxoplasmosis in a barred owl (Strix varia) from Québec, Canada. Avian Dis (1997) 0.81

Concentrations and chromatographic profile of DDT metabolites and polychlorobiphenyl (PCB) residues in stranded beluga whales (Delphinapterus leucas) from the St. Lawrence Estuary, Canada. Arch Environ Contam Toxicol (1986) 0.80

Preliminary evaluation on the use of homing pigeons as a biomonitor in urban areas. Ecotoxicology (2009) 0.80

Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells. Cancer Gene Ther (1997) 0.80

Salmonella infection in wild birds from Quebec. Can Vet J (1997) 0.80

Transitional vacuole formation following a bolus infusion of PEG-hemoglobin in the rat. Artif Cells Blood Substit Immobil Biotechnol (1996) 0.80

Modulation of adrenal catecholamine release by PACAP in vivo. Am J Physiol (1999) 0.80

Neoplastic and nonneoplastic hepatic changes in lake whitefish (Coregonus clupeaformis) from the St. Lawrence River, Quebec, Canada. Environ Health Perspect (1998) 0.80

The carboxylation efficiency of the vitamin K-dependent clotting factors: studies with factor IX. Haemophilia (2008) 0.79

Functional characterization of a piscine retroviral promoter. J Gen Virol (1999) 0.79

Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein. J Biol Chem (1994) 0.79

Metastatic mammary adenocarcinomas in two beluga whales (Delphinapterus leucas) from the St Lawrence Estuary, Canada. Vet Rec (2000) 0.79

Galectin 3-binding protein is a potential contaminant of recombinantly produced factor IX. Haemophilia (2007) 0.79

Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells. Stem Cells (1998) 0.79

Expression of the human apolipoprotein AI gene fused to the E. coli gene for beta-galactosidase. FEBS Lett (1986) 0.78

In vivo effects in mice of an anti-T cell immunotoxin. J Immunol (1989) 0.78

Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin. Cancer (1994) 0.78

Ventricular activation of the atrial natriuretic factor gene in acute myocardial infarction. N Engl J Med (1988) 0.78

Adrenal hyperplastic and degenerative changes in beluga whales. J Wildl Dis (1997) 0.78

Seroprevalence of leptospirosis in lynx and bobcats from Quebec. Can Vet J (2000) 0.78

Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells. Gene Ther (2002) 0.78

Seroprevalence of selected viral infections in a population of beluga whales (Delphinapterus leucas) in Canada. Vet Rec (1999) 0.78

Position-dependent variegation of a CD4 minigene with targeted expression to mature CD4+ T cells. J Immunol (1997) 0.78

Neurosedation in dentistry of the disabled patient: the use of midazolam, propofol, and remifentanil. Minerva Stomatol (2006) 0.78

Uterine adenocarcinoma with abdominal carcinomatosis in a beluga whale. J Wildl Dis (1998) 0.78

Fibroleiomyomas of the tubular genitalia in female beluga whales. J Vet Diagn Invest (2000) 0.77

Transfection of murine fibroblast cells with human cytidine deaminase cDNA confers resistance to cytosine arabinoside. Anticancer Drugs (1996) 0.77

Adenomatous hyperplasia of the thyroid gland in beluga whales (Delphinapterus leucas) from the St. Lawrence Estuary and Hudson Bay, Quebec, Canada. Vet Pathol (2003) 0.77

Toxoplasmosis in captive dolphins (Tursiops truncatus) and walrus (Odobenus rosmarus). J Parasitol (2009) 0.77

Preservation of graft-versus-infection effects after suicide gene therapy for prevention of graft-versus-host disease. Hum Gene Ther (2000) 0.77

Phenotyping of beluga whale blood lymphocytes using monoclonal antibodies. Dev Comp Immunol (1998) 0.77

Seroprevalence of Toxoplasma gondii in Canadian pinnipeds. J Wildl Dis (2004) 0.77

Disruption of NF-kappa B signaling and chemokine gene activation by retroviral mediated expression of IKK gamma/NEMO mutants. Virology (2001) 0.77

A novel and simplified method of culture of human blood-derived early endothelial progenitor cells for the treatment of ischemic vascular disease. Cell Transplant (2011) 0.77

Tumors in wild adult raccoons from a suburban area. Can Vet J (1999) 0.77

Reducing the heterogeneity of chemically conjugated targeted toxins: homogeneous basic FGF-saporin. Anal Biochem (1993) 0.76

Interleukin-2 enhances angiogenesis and preserves cardiac function following myocardial infarction. Cytokine (2011) 0.76

Purification of functional T lymphocytes from splenocytes of the beluga whales (Delphinapterus leucas). Dev Comp Immunol (2000) 0.76

Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia. Leukemia (1997) 0.76

Immune functions in beluga whales (Delphinapterus leucas): evaluation of mitogen-induced blastic transformation of lymphocytes from peripheral blood, spleen and thymus. Vet Immunol Immunopathol (1996) 0.76

Cutaneous avian pox in a house sparrow. Can Vet J (1996) 0.75

Basic fibroblast growth factor in cells derived from Dupuytren's contracture: synthesis, presence, and implications for treatment of the disease. J Hand Surg Am (1992) 0.75

The influence of polyethylene glycol conjugation on bovine hemoglobin's intrinsic effect on the gastrointestinal system of the rat. Life Sci (1996) 0.75

[Klinefelter's syndrome in 2 monozygotic twins with dissimilar dermatoglyphs]. Ann Endocrinol (Paris) (1967) 0.75

Evaluation of the oxygen delivery ability of PEG-hemoglobin in Sprague-Dawley rats during hemodilution. Artif Cells Blood Substit Immobil Biotechnol (1998) 0.75

[BCG and prevention in a population supervised by the antitubercular dispensaries]. Acta Tuberc Pneumol Belg (1973) 0.75

Dermatophilus-like infection in beluga whales, Delphinapterus leucas, from the St. Lawrence estuary. Vet Dermatol (2001) 0.75